Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goi Sakamoto

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Cancer Letters|March 26, 2002
Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapyMichiko Tsuneizumi, Mitsuru Emi, Akira Hirano, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2007
Diagnostic ultrasonography and mammography for invasive and noninvasive breast cancer in women aged 30 to 39 yearsTomo Osako, Kaoru Takahashi, Takuji Iwase, et al.
Tumori|May 18, 2004
Efficacy and safety of trastuzumab as a single agent in heavily pretreated patients with HER-2/neu-overexpressing metastatic breast cancerMasataka Sawaki, Yoshinori Ito, Keiichiro Tada, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Malignant melanoma originating on the female nipple: a case reportSatoki Kinoshita, Kazuhisa Yoshimoto, Shigeya Kyoda, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2006
Efficacy and safety of combined trastuzumab and Paclitaxel therapy as a second-line treatment in women with metastatic breast cancer: a single institutional experienceKeiko Furukawa, Yoshinori Ito, Shunji Takahashi, et al.
Breast Cancer (Tokyo, Japan)|August 20, 2002
Correlation of allelic losses and clinicopathological factors in 504 primary breast cancersTakemitsu Nagahata, Akira Hirano, Yoshihito Utada, et al.
Breast Cancer (Tokyo, Japan)|April 29, 2005
A case of carcinosarcoma of the breastNahomi Tokudome, Goi Sakamoto, Takehiko Sakai, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 10, 2009
Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breastNaoko Honma, Shigehira Saji, Rie Kurabayashi, et al.
Breast Cancer (Tokyo, Japan)|June 7, 2006
High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancerMasataka Sawaki, Yoshinori Ito, Futoshi Akiyama, et al.
Tumori|May 18, 2004
Paclitaxel administered weekly in patients with docetaxel-resistant metastatic breast cancer: a single-center studyMasataka Sawaki, Yoshinori Ito, Daigo Hashimoto, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Cancer Letters|March 26, 2002
Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapyMichiko Tsuneizumi, Mitsuru Emi, Akira Hirano, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2007
Diagnostic ultrasonography and mammography for invasive and noninvasive breast cancer in women aged 30 to 39 yearsTomo Osako, Kaoru Takahashi, Takuji Iwase, et al.
Tumori|May 18, 2004
Efficacy and safety of trastuzumab as a single agent in heavily pretreated patients with HER-2/neu-overexpressing metastatic breast cancerMasataka Sawaki, Yoshinori Ito, Keiichiro Tada, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Malignant melanoma originating on the female nipple: a case reportSatoki Kinoshita, Kazuhisa Yoshimoto, Shigeya Kyoda, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2006
Efficacy and safety of combined trastuzumab and Paclitaxel therapy as a second-line treatment in women with metastatic breast cancer: a single institutional experienceKeiko Furukawa, Yoshinori Ito, Shunji Takahashi, et al.
Breast Cancer (Tokyo, Japan)|August 20, 2002
Correlation of allelic losses and clinicopathological factors in 504 primary breast cancersTakemitsu Nagahata, Akira Hirano, Yoshihito Utada, et al.
Breast Cancer (Tokyo, Japan)|April 29, 2005
A case of carcinosarcoma of the breastNahomi Tokudome, Goi Sakamoto, Takehiko Sakai, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 10, 2009
Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breastNaoko Honma, Shigehira Saji, Rie Kurabayashi, et al.
Breast Cancer (Tokyo, Japan)|June 7, 2006
High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancerMasataka Sawaki, Yoshinori Ito, Futoshi Akiyama, et al.
Tumori|May 18, 2004
Paclitaxel administered weekly in patients with docetaxel-resistant metastatic breast cancer: a single-center studyMasataka Sawaki, Yoshinori Ito, Daigo Hashimoto, et al.
Pageof 6